Virulence Enhancement Agents for Haemophilus influenzae type B infection in mice
- PMID: 10090102
Virulence Enhancement Agents for Haemophilus influenzae type B infection in mice
Similar articles
-
Intraperitoneal inoculation of Haemophilus influenzae local isolates in BALB/c mice model in the presence and absence of virulence enhancement agents.Indian J Med Microbiol. 2013 Apr-Jun;31(2):148-53. doi: 10.4103/0255-0857.115236. Indian J Med Microbiol. 2013. PMID: 23867671
-
Mouse models of infection for Neisseria meningitidis B,2b and Haemophilus influenzae type b diseases.Can J Microbiol. 1986 Jan;32(1):33-7. doi: 10.1139/m86-007. Can J Microbiol. 1986. PMID: 3084050
-
The pathogenesis of disease due to type b Haemophilus influenzae.Methods Mol Med. 2003;71:29-50. doi: 10.1385/1-59259-321-6:29. Methods Mol Med. 2003. PMID: 12374027 Review. No abstract available.
-
Is a NAD pyrophosphatase activity necessary for Haemophilus influenzae type b multiplication in the blood stream?Int J Med Microbiol. 2001 Aug;291(3):219-25. doi: 10.1078/1438-4221-00122. Int J Med Microbiol. 2001. PMID: 11554562
-
[Haemophilus influenzae type b--active prevention].Med Wieku Rozwoj. 2008 Apr-Jun;12(2 Pt 2):661-5. Med Wieku Rozwoj. 2008. PMID: 19418941 Review. Polish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical